Robert Szulcek

1.6k total citations
34 papers, 1.0k citations indexed

About

Robert Szulcek is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert Szulcek has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert Szulcek's work include Pulmonary Hypertension Research and Treatments (16 papers), MicroRNA in disease regulation (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Robert Szulcek is often cited by papers focused on Pulmonary Hypertension Research and Treatments (16 papers), MicroRNA in disease regulation (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Robert Szulcek collaborates with scholars based in Netherlands, United States and Germany. Robert Szulcek's co-authors include Harm Jan Bogaard, Geerten P. van Nieuw Amerongen, Kondababu Kurakula, Marie‐José Goumans, Zhenlong Chen, Richard D. Minshall, Beatrijs Bartelds, Diederik E. van der Feen, Rolf M.F. Berger and Guido P. L. Bossers and has published in prestigious journals such as Circulation, Nature Communications and PLoS ONE.

In The Last Decade

Robert Szulcek

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Szulcek Netherlands	17	389	372	207	130	114	34	1.0k
Elizabeth M. Leaf United States	13	442 1.1×	260 0.7×	138 0.7×	110 0.8×	44 0.4×	25	1.7k
Joseph Bird United Kingdom	16	209 0.5×	246 0.7×	163 0.8×	78 0.6×	70 0.6×	34	1.1k
Andrea‐Hermina Györfi Germany	14	422 1.1×	327 0.9×	60 0.3×	76 0.6×	98 0.9×	31	1.1k
Ke Yuan United States	16	248 0.6×	373 1.0×	121 0.6×	93 0.7×	43 0.4×	45	790
Jan van Bezu Netherlands	18	345 0.9×	126 0.3×	105 0.5×	54 0.4×	121 1.1×	23	959
Xiangwei Huang China	10	414 1.1×	405 1.1×	68 0.3×	68 0.5×	89 0.8×	16	1.2k
Ashish Misra Australia	17	441 1.1×	127 0.3×	131 0.6×	116 0.9×	55 0.5×	37	1.1k
Janet Chamberlain United Kingdom	19	445 1.1×	178 0.5×	187 0.9×	127 1.0×	60 0.5×	29	1.2k
Jeff Crosby United States	14	688 1.8×	173 0.5×	138 0.7×	144 1.1×	60 0.5×	30	1.4k
Andrew J. Haak United States	21	554 1.4×	420 1.1×	71 0.3×	88 0.7×	127 1.1×	57	1.5k

Countries citing papers authored by Robert Szulcek

Since Specialization

Citations

This map shows the geographic impact of Robert Szulcek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Szulcek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Szulcek more than expected).

Fields of papers citing papers by Robert Szulcek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Szulcek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Szulcek. The network helps show where Robert Szulcek may publish in the future.

Co-authorship network of co-authors of Robert Szulcek

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Szulcek. A scholar is included among the top collaborators of Robert Szulcek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Szulcek. Robert Szulcek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Liu, Shao‐Fei, Marieluise Kirchner, Felix Hennig, et al.. (2025). Remodelling of the endothelial extracellular matrix promotes smooth muscle cell hyperplasia in pulmonary hypertension due to left heart disease. Cardiovascular Research. 121(18). 2939–2953. 1 indexed citations

2.

Banerjee, Priyanka, et al.. (2024). An exploration into CTEPH medications: Combining natural language processing, embedding learning, in vitro models, and real-world evidence for drug repurposing. PLoS Computational Biology. 20(9). e1012417–e1012417. 1 indexed citations

3.

Nazari‐Shafti, Timo Z., Sebastian Neuber, Heike Meýborg, et al.. (2023). Endothelial damage inhibitor preserves the integrity of venous endothelial cells from patients undergoing coronary bypass surgery. European Journal of Cardio-Thoracic Surgery. 64(6). 4 indexed citations

4.

Blanco, Isabel, Robert Szulcek, Wim Timens, et al.. (2022). Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension. Scientific Reports. 12(1). 2283–2283. 16 indexed citations

5.

Szulcek, Robert, et al.. (2021). Extracellular Matrix Protein Ratios in the Human Heart and Vessels: How to Distinguish Pathological From Physiological Changes?. Frontiers in Physiology. 12. 708656–708656. 46 indexed citations

6.

Manz, Xue D., Hugo J. Albers, Petr Symersky, et al.. (2020). In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time. Journal of Visualized Experiments. 2 indexed citations

7.

Feen, Diederik E. van der, Guido P. L. Bossers, Quint A. J. Hagdorn, et al.. (2020). Cellular senescence impairs the reversibility of pulmonary arterial hypertension. Science Translational Medicine. 12(554). 85 indexed citations

8.

Sun, Xiao‐Qing, Ingrid Schalij, Stine Andersen, et al.. (2020). Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension. American Journal of Respiratory Cell and Molecular Biology. 64(3). 331–343. 16 indexed citations

9.

Russomanno, Giusy, Sandro Satta, Vahitha B. Abdul‐Salam, et al.. (2020). Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension. Nature Communications. 11(1). 1185–1185. 69 indexed citations

10.

Manz, Xue D., Hugo J. Albers, Petr Symersky, et al.. (2020). In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time. Journal of Visualized Experiments. 14 indexed citations

11.

Gomez‐Puerto, Maria Catalina, Robert Szulcek, Maarten van Dinther, et al.. (2019). Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension. The Journal of Pathology. 249(3). 356–367. 37 indexed citations

12.

Feen, Diederik E. van der, Kondababu Kurakula, Ève Tremblay, et al.. (2019). Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 200(7). 910–920. 96 indexed citations

13.

Dekker, Nicole, Anoek L. I. van Leeuwen, Robert Szulcek, et al.. (2019). Microcirculatory perfusion disturbances following cardiac surgery with cardiopulmonary bypass are associated with in vitro endothelial hyperpermeability and increased angiopoietin-2 levels. Critical Care. 23(1). 117–117. 26 indexed citations

14.

Szulcek, Robert, Christian Bollensdorff, Peter L. Hordijk, & Matthias Gabriel. (2018). The covalently immobilized antimicrobial peptide LL37 acts as a VEGF mimic and stimulates endothelial cell proliferation. Biochemical and Biophysical Research Communications. 496(3). 887–890. 7 indexed citations

15.

Szulcek, Robert, Chris Happé, Nina Rol, et al.. (2016). Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension: Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage. American Journal of Respiratory and Critical Care Medicine. 193(12). 1410–1420. 73 indexed citations

16.

Haasdijk, Remco, Wijnand K. den Dekker, Caroline Cheng, et al.. (2016). THSD1preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE^−/−mice. Cardiovascular Research. 110(1). 129–139. 24 indexed citations

17.

Szulcek, Robert, Jan van Bezu, Johannes Boonstra, Jack J. W. A. van Loon, & Geerten P. van Nieuw Amerongen. (2015). Transient Intervals of Hyper-Gravity Enhance Endothelial Barrier Integrity: Impact of Mechanical and Gravitational Forces Measured Electrically. PLoS ONE. 10(12). e0144269–e0144269. 19 indexed citations

18.

Szulcek, Robert, Harm Jan Bogaard, & Geerten P. van Nieuw Amerongen. (2014). Electric Cell-substrate Impedance Sensing for the Quantification of Endothelial Proliferation, Barrier Function, and Motility. Journal of Visualized Experiments. 33 indexed citations

19.

Szulcek, Robert, Harm Jan Bogaard, & Geerten P. van Nieuw Amerongen. (2014). Electric Cell-substrate Impedance Sensing for the Quantification of Endothelial Proliferation, Barrier Function, and Motility. Journal of Visualized Experiments. 172 indexed citations

20.

Bakhshi, Farnaz R., Mao Mao, Ayesha N. Shajahan‐Haq, et al.. (2013). Nitrosation‐Dependent Caveolin 1 Phosphorylation, Ubiquitination, and Degradation and its Association with Idiopathic Pulmonary Arterial Hypertension. Pulmonary Circulation. 3(4). 816–830. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact